港股異動丨葉氏化工集團(0408.HK)漲逾4% 出售粉嶺物業賺近7000萬港元
格隆匯7月19日丨葉氏化工集團(0408.HK)漲逾4%,報4.53港元,高見4.7港元創逾七年新高,總市值25億港元。公司上週五收市後公佈,公司出售旗下間接全資附屬公司大勇投資的全部權益及轉讓銷售貸款,總現金代價為2.83億港元。大勇投資主要從事物業控股,持有粉嶺上水市地段第35號的整幅土地或地塊,該物業包括位於香港粉嶺業暢街13號的一幢五層樓工業大廈。公司稱,出售事項被視為集團變現其於大勇投資之投資的機會,符合集團的策略發展計劃,出售事項的所得款項淨額將約為2.79億港元,料將錄得約6952.4萬港元淨收益。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.